ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/11/14 | 2,155 | 2,190 | 2,154 | 2,171 | +27 | +1.3% | 121,300 |
2017/11/13 | 2,131 | 2,154 | 2,131 | 2,144 | -14 | -0.6% | 76,300 |
2017/11/10 | 2,116 | 2,161 | 2,116 | 2,158 | +42 | +2% | 180,600 |
2017/11/09 | 2,125 | 2,148 | 2,102 | 2,116 | -4 | -0.2% | 168,700 |
2017/11/08 | 2,132 | 2,145 | 2,110 | 2,120 | -39 | -1.8% | 94,400 |
2017/11/07 | 2,184 | 2,184 | 2,130 | 2,159 | -36 | -1.6% | 201,700 |
2017/11/06 | 2,020 | 2,197 | 2,015 | 2,195 | +223 | +11.3% | 716,100 |
2017/11/02 | 1,972 | 1,977 | 1,957 | 1,972 | -7 | -0.4% | 93,900 |
2017/11/01 | 1,978 | 1,983 | 1,965 | 1,979 | -5 | -0.3% | 145,500 |
2017/10/31 | 2,002 | 2,002 | 1,977 | 1,984 | -22 | -1.1% | 96,000 |
2017/10/30 | 2,015 | 2,022 | 2,000 | 2,006 | -31 | -1.5% | 122,400 |
2017/10/27 | 2,014 | 2,040 | 2,010 | 2,037 | +38 | +1.9% | 162,000 |
2017/10/26 | 2,007 | 2,007 | 1,996 | 1,999 | -14 | -0.7% | 81,900 |
2017/10/25 | 2,019 | 2,021 | 2,009 | 2,013 | -6 | -0.3% | 110,300 |
2017/10/24 | 2,020 | 2,022 | 2,006 | 2,019 | -4 | -0.2% | 101,000 |
2017/10/23 | 1,969 | 2,034 | 1,969 | 2,023 | +64 | +3.3% | 241,200 |
2017/10/20 | 1,971 | 1,976 | 1,952 | 1,959 | -13 | -0.7% | 124,400 |
2017/10/19 | 1,989 | 1,989 | 1,972 | 1,972 | -10 | -0.5% | 94,100 |
2017/10/18 | 1,979 | 1,989 | 1,975 | 1,982 | +2 | +0.1% | 71,000 |
2017/10/17 | 2,016 | 2,016 | 1,978 | 1,980 | -35 | -1.7% | 157,700 |
2017/10/16 | 2,010 | 2,022 | 2,007 | 2,015 | ±0 | ±0% | 83,800 |
2017/10/13 | 2,010 | 2,018 | 2,004 | 2,015 | -2 | -0.1% | 133,300 |
2017/10/12 | 2,014 | 2,022 | 2,007 | 2,017 | +6 | +0.3% | 85,700 |
2017/10/11 | 2,008 | 2,015 | 2,003 | 2,011 | -2 | -0.1% | 99,300 |
2017/10/10 | 2,008 | 2,017 | 2,005 | 2,013 | +5 | +0.2% | 58,200 |
2017/10/06 | 2,010 | 2,013 | 2,003 | 2,008 | +2 | +0.1% | 82,500 |
2017/10/05 | 2,007 | 2,013 | 2,003 | 2,006 | ±0 | ±0% | 97,200 |
2017/10/04 | 2,022 | 2,022 | 2,003 | 2,006 | -12 | -0.6% | 84,500 |
2017/10/03 | 2,028 | 2,034 | 2,003 | 2,018 | -19 | -0.9% | 127,000 |
2017/10/02 | 2,018 | 2,043 | 2,018 | 2,037 | +26 | +1.3% | 181,600 |
2017/09/29 | 2,000 | 2,012 | 1,998 | 2,011 | ±0 | ±0% | 153,600 |
2017/09/28 | 2,020 | 2,020 | 2,003 | 2,011 | -7 | -0.3% | 102,900 |
2017/09/27 | 2,011 | 2,019 | 2,001 | 2,018 | -11 | -0.5% | 116,000 |
2017/09/26 | 2,027 | 2,044 | 2,023 | 2,029 | +3 | +0.1% | 224,100 |
2017/09/25 | 2,015 | 2,027 | 2,006 | 2,026 | +17 | +0.8% | 170,100 |
2017/09/22 | 2,013 | 2,014 | 1,999 | 2,009 | +1 | ±0% | 111,200 |
2017/09/21 | 2,014 | 2,016 | 2,003 | 2,008 | +2 | +0.1% | 132,900 |
2017/09/20 | 2,011 | 2,018 | 2,003 | 2,006 | -17 | -0.8% | 125,600 |
2017/09/19 | 2,028 | 2,030 | 2,015 | 2,023 | +2 | +0.1% | 112,700 |
2017/09/15 | 2,018 | 2,028 | 2,011 | 2,021 | +10 | +0.5% | 122,400 |
2017/09/14 | 2,030 | 2,032 | 2,005 | 2,011 | -11 | -0.5% | 114,000 |
2017/09/13 | 2,034 | 2,038 | 2,022 | 2,022 | -13 | -0.6% | 78,400 |
2017/09/12 | 2,040 | 2,042 | 2,032 | 2,035 | +7 | +0.3% | 75,500 |
2017/09/11 | 2,025 | 2,048 | 2,018 | 2,028 | +11 | +0.5% | 157,500 |
2017/09/08 | 1,981 | 2,024 | 1,981 | 2,017 | +28 | +1.4% | 190,900 |
2017/09/07 | 2,015 | 2,021 | 1,983 | 1,989 | -26 | -1.3% | 278,100 |
2017/09/06 | 2,002 | 2,020 | 1,992 | 2,015 | +6 | +0.3% | 103,800 |
2017/09/05 | 2,017 | 2,022 | 2,005 | 2,009 | -1 | ±0% | 133,600 |
2017/09/04 | 2,025 | 2,025 | 2,004 | 2,010 | -20 | -1% | 116,100 |
2017/09/01 | 2,023 | 2,036 | 2,013 | 2,030 | +13 | +0.6% | 181,300 |
1901~
1950
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 266,500円 | +21.7% | +999.9% | 0.00% | 12.28倍 | 4.20倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 248,000円 | +4.1% | -3.1% | 2.34% | 21.55倍 | 1.88倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,700円 | -2.4% | -52.3% | 3.76% | 18.15倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム